| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $749,999 | 3 | 100 |
Sells | $0 | 0 | 0 |
| KLEMP WALTER V | CEO and President | 1 | $400,000 | 0 | $0 | $400,000 |
| Foster Jonathan P. | Chief Financial Officer | 1 | $220,000 | 0 | $0 | $220,000 |
| PICKER DONALD H | Chief Science Officer | 1 | $130,000 | 0 | $0 | $130,000 |
Moleculin Biotech, Inc. is a clinical-stage pharmaceutical company dedicated to advancing therapeutic candidates designed to combat highly aggressive cancers and viral infections. Their primary investigational drug, Annamycin, is currently undergoing Phase 1/2 clinical trials. These trials aim to assess its efficacy against acute myeloid leukemia (AML) that has relapsed or is resistant to prior therapies, as well as malignancies that have spread to the lungs. WP1066, a prominent immune/transcription modulator for the company, is presently in …
Over the last 12 months, insiders at Moleculin Biotech, Inc. have bought $749,999 and sold $0 worth of Moleculin Biotech, Inc. stock.
On average, over the past 5 years, insiders at Moleculin Biotech, Inc. have bought $362,842 and sold $0 worth of stock each year.
Highest buying activity among insiders over the last 12 months: KLEMP WALTER V (CEO and President) — $400,000. Foster Jonathan P. (Chief Financial Officer) — $220,000. PICKER DONALD H (Chief Science Officer) — $130,000.
The last purchase of 533,333 shares for transaction amount of $400,000 was made by KLEMP WALTER V (CEO and President) on 2026‑08‑03.
| 2026-08-03 | KLEMP WALTER V | CEO and President | 533,333 22.8193% | $0.75 | $400,000 | +22.82% | ||
| 2026-08-03 | Foster Jonathan P. | Chief Financial Officer | 293,333 12.5506% | $0.75 | $220,000 | +22.82% | ||
| 2026-08-03 | PICKER DONALD H | Chief Science Officer | 173,333 7.4162% | $0.75 | $130,000 | +22.82% | ||
| 2025-06-23 | KLEMP WALTER V | CEO and President | 675,675 6.4607% | $0.37 | $250,000 | -31.68% | ||
| 2025-06-23 | Foster Jonathan P. | Chief Financial Officer | 270,270 2.5843% | $0.37 | $100,000 | -31.68% | ||
| 2023-12-26 | KLEMP WALTER V | CEO and President | 188,404 0.6709% | $0.69 | $129,999 | -59.21% | ||
| 2023-12-26 | Foster Jonathan P. | Chief Financial Officer | 28,986 0.1032% | $0.69 | $20,000 | -59.21% | ||
| 2023-12-26 | George Robert E. | director | 14,493 0.0516% | $0.69 | $10,000 | -59.21% | ||
| 2022-11-25 | KLEMP WALTER V | CEO and President | 45,000 0.1562% | $1.28 | $57,632 | -49.25% | ||
| 2022-11-21 | KLEMP WALTER V | CEO and President | 22,500 0.0729% | $1.15 | $25,866 | -46.83% | ||
| 2022-11-17 | KLEMP WALTER V | CEO and President | 24,742 0.0849% | $1.02 | $25,257 | -36.28% | ||
| 2022-11-16 | KLEMP WALTER V | CEO and President | 85,213 0.2832% | $0.97 | $82,614 | -34.97% | ||
| 2017-08-16 | Sale | Priebe Waldemar | 10 percent owner | 200,000 0.6259% | $1.70 | $340,600 | -30.57% | |
| 2017-08-16 | Sale | KLEMP WALTER V | Chief Executive Officer | 200,000 0.6259% | $1.70 | $340,600 | -30.57% | |
| 2017-05-11 | KLEMP WALTER V | Chief Executive Officer | 24,000 0.133% | $0.81 | $19,440 | +128.51% | ||
| 2017-05-05 | Northcut Jacqueline | director | 2,000 0.0057% | $0.41 | $820 | +133.75% | ||
| 2017-04-28 | George Robert E. | director | 2,000 0.0058% | $0.47 | $938 | +105.49% | ||
| 2017-04-25 | Foster Jonathan P. | Exec. Vice President & CFO | 20,000 0.1113% | $0.86 | $17,298 | +114.94% |
| KLEMP WALTER V | CEO and President | 564340 55.366% | $4.68M | 8 | 1 | <0.0001% |
| Foster Jonathan P. | Chief Financial Officer | 305673 29.9888% | $2.54M | 4 | 0 | <0.0001% |
| PICKER DONALD H | Chief Science Officer | 174086 17.0792% | $1.44M | 1 | 0 | |
| George Robert E. | director | 14660 1.4383% | $121,678.00 | 2 | 0 | |
| Northcut Jacqueline | director | 1000 0.0981% | $8,300.00 | 1 | 0 |
$13,664,154 | 40 | -70.35% | $7.05M | |
$76,600 | 22 | -38.58% | $10.49M | |
$812,698 | 12 | -57.09% | $7.89M | |
$4,146,041 | 11 | -40.86% | $8.55M | |
$120,379 | 10 | -24.48% | $7.65M |
| Increased Positions | 10 | +25.64% | 75,896 | +243.69% |
| Decreased Positions | 18 | -46.15% | 11,816 | -37.94% |
| New Positions | 5 | New | 56,352 | New |
| Sold Out Positions | 13 | Sold Out | 11,450 | Sold Out |
| Total Postitions | 31 | -20.51% | 95,224 | +205.75% |
| Vanguard Group Inc | $35.00 | 0.32% | 9,597 | +8,360 | +675.83% | 2025-09-30 |
| Geode Capital Management, Llc | $30.00 | 0.28% | 8,328 | +7,227 | +656.4% | 2025-09-30 |
| Hrt Financial Lp | $17.00 | 0.15% | 4,608 | +4,608 | New | 2025-09-30 |
| Lpl Financial Llc | $8.00 | 0.08% | 2,323 | +80 | +3.57% | 2025-09-30 |
| Ieq Capital, Llc | $5.00 | 0.05% | 1,455 | +1,455 | New | 2025-09-30 |
| Wealth Dimensions Group, Ltd. | $3.00 | 0.03% | 800 | +800 | New | 2025-09-30 |
| Rockefeller Capital Management L.P. | $2.00 | 0.02% | 580 | +580 | New | 2025-09-30 |
| Cambridge Investment Research Advisors, Inc. | $2.00 | 0.02% | 511 | 0 | 0% | 2025-09-30 |
| Goldman Sachs Group Inc | $2.00 | 0.02% | 510 | +510 | New | 2025-09-30 |
| Blackrock, Inc. | $2.00 | 0.02% | 495 | 0 | 0% | 2025-09-30 |